Thermo Fisher Scientific IncTMO:NYQ

119.39
0.96 / 0.80%
4.41m
48.05%
0.9562
Close in USDToday's changeShares traded1 year changeBeta
As of Apr 23 2014 21:02 BST.Data delayed by at least 15 minutes.

Summary

On Wednesday, Thermo Fisher Scientific Inc (TMO:NYQ) closed at 119.39, 6.46% below its 52-week high of 127.63, set on Mar 06, 2014.

52-week range
Today
79.56
Apr 26 2013
127.63
Mar 06 2014
Markit short selling activity
Low
Medium
High
Open121.71
Day high121.77
Day low114.53
Bid114.29
Offer119.98
Previous close120.35
Average volume2.21m
Shares outstanding398.94m
Free float395.02m
P/E (TTM)34.43
Market cap48.01bn USD
EPS (TTM)3.50 USD
Annual div (TTM)0.60 USD
Annual div yield (TTM)0.50%
Div ex-dateMar 13 2014
Div pay-dateApr 15 2014

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Thermo Fisher Scientific Inc-0.27%-2.86%+22.48%+48.05%+268.60%
S&P 500 INDEX+0.93%+0.70%+7.63%+19.05%+120.63%
USA/HEALTH CARE+1.77%-0.98%+8.82%+16.80%--
USA/LIFE SCI TOOLS&SVC+2.82%-1.60%+16.31%+29.65%--
As of Apr 23 2014 21:02 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.